聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 48 分钟 40 秒 前

Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis

周五, 02/26/2016 - 13:37
INDIANAPOLIS, Feb. 26, 2016 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for ixekizu...
Biopharmaceuticals, Regulatory
Eli Lilly, ixekizumab, plaque psoriasis

Catalyst Pharmaceuticals Appoints Brian Elsbernd as Senior Vice President of Legal and Compliance

周五, 02/26/2016 - 13:29
CORAL GABLES, Fla., Feb. 26, 2016 -- (Healthcare Sales & Marketing Network) -- Catalyst Pharmaceuticals, Inc. (CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, tod...
Biopharmaceuticals, Personnel
Catalyst Pharmaceuticals

AbbVie Receives EMA Orphan Drug Designation for Investigational Compound Venetoclax for the Treatment of Acute Myeloid Leukemia (AML)

周五, 02/26/2016 - 13:08
FDA also recently granted venetoclax Breakthrough Therapy Designation (BTD) and Orphan Drug Designation (ODD) for the treatment of patients with AML AML is the most common type of acute leukemia in adults NORTH CHICAGO, Ill., Feb. 26, 2016 -- (Health...
Biopharmaceuticals, Oncology, Regulatory
AbbVie, Orphan Drug Designation, venetoclax, acute myeloid leukemia

Valeritas Announces Leadership and Board of Directors Changes

周四, 02/25/2016 - 20:42
John Timberlake Named as Interim CEO BRIDGEWATER, New Jersey, February 25, 2016 -- (Healthcare Sales & Marketing Network) -- Valeritas, Inc. announced today changes to its executive team this week. John Timberlake has been named the company's new Inter...
Devices, Endocrinology, Personnel
Valeritas , V-Go, Insulin Delivery device, diabetes

Sagent Pharmaceuticals Names Frank Harmon Executive Vice President Global Operations

周四, 02/25/2016 - 20:34
Newly Created Position Supports Long-Term Growth Strategy to Expand Product Offerings and Enhance Operational Performance SCHAUMBURG, Ill., Feb. 25, 2016 -- (Healthcare Sales & Marketing Network) -- Sagent Pharmaceuticals, Inc. (SGNT), a leading provide...
Biopharmaceuticals, Personnel
Sagent Pharmaceuticals

Anthem BCBS Georgia and Virginia Contracted to Cover Cologuard as In-Network Service

周四, 02/25/2016 - 13:45
Reimbursement for Cologuard continues expansion; will reach nearly half of Anthem's members MADISON, Wis., Feb. 25, 2016 -- (Healthcare Sales & Marketing Network) -- Exact Sciences Corp. (EXAS) today announced that under recently signed contracts, Colo...
Diagnostics, Oncology, Reimbursement
Exact Sciences, Cologuard, colorectal cancer

Accuray and GE Capital Healthcare Equipment Finance Announce Healthcare Financing Collaboration Agreement

周四, 02/25/2016 - 13:35
New Agreement Provides Healthcare Professionals with Streamlined, Cost-Effective Options for Accessing the CyberKnife® and TomoTherapy® Systems PARIS and LONDON, February 25, 2016 -- (Healthcare Sales & Marketing Network) -- Accuray Europe and ...
Devices, Oncology
Accuray, GE Capital, CyberKnife, TomoTherapy, radiotherapy

Precision Medical Devices, Inc. Awarded Surgical Instrument Agreement With Premier, Inc.

周三, 02/24/2016 - 16:32
NEW BRUNSWICK, N.J., Feb. 24, 2016 -- (Healthcare Sales & Marketing Network) -- Precision Medical Devices, Inc. has been awarded a group purchasing agreement for Surgical Instruments with Premier, Inc. Effective February 1, 2016, the new agreement allows ...
Devices, Surgery, Group Purchasing
Precision Medical Devices

Forty Seven Inc. Completes $75M Series A Financing and Licenses Technology from Stanford University to Advance Next Generation Immuno-Oncology Programs

周三, 02/24/2016 - 16:25
Lead program stimulating ingestion of cancer cells by the immune system is in two Phase 1 clinical trials for solid tumors and acute myeloid leukemia (AML) PALO ALTO, Calif., Feb. 24, 2016 -- (Healthcare Sales & Marketing Network) -- Forty Seven Inc., ...
Biopharmaceuticals, Oncology, Venture Capital, Licensing
Forty Seven Inc, Hu5F9-G4, CD47 receptor

Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE(R) (loxapine) inhalation powder

周三, 02/24/2016 - 13:48
MOUNTAIN VIEW, Calif., Feb. 24, 2016 -- (Healthcare Sales & Marketing Network) -- Alexza Pharmaceuticals, Inc. (ALXA) announced today that it has reacquired U.S. commercial rights for ADASUVE® (loxapine) inhalation powder from Teva Pharmaceuticals USA...
Biopharmaceuticals, Acquisitions
Alexza Pharmaceuticals, Teva Pharmaceutical, ADASUVE, loxapine

Pixium Vision Implants IRIS(R) II, First Epi-Retinal Implant with 150 Electrodes

周三, 02/24/2016 - 13:38
A major step forward in bionic vision for patients with retinitis pigmentosa PARIS--(Healthcare Sales & Marketing Network)--Pixium Vision (FR0011950641 – PIX) a company developing innovative bionic vision systems to allow patients who have lost their si...
Devices, Ophthalmology
Pixium Vision, IRIS II, epi-retinal implant, retinitis pigmentosa, bionic vision

FDA Accepts and Grants Priority Review for AVYCAZ(R) (ceftazidime and avibactam) Supplemental New Drug Application (sNDA)

周三, 02/24/2016 - 13:31
Application Seeks to Expand AVYCAZ Label to Include Phase 3 Clinical Data for the Treatment of Complicated Intra-Abdominal Infections (cIAI), in Combination with Metronidazole DUBLIN, Feb. 24, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan ...
Biopharmaceuticals, FDA
Allergan, AVYCAZ , intra-abdominal infection, ceftazidime, avibactam

PolyPid Announces Completion of $22 Million Series D Financing

周三, 02/24/2016 - 13:22
PETAH TIKVA, Israel, February 24, 2016 -- (Healthcare Sales & Marketing Network) -- PolyPid Ltd., an emerging clinical-stage specialty pharmaceutical company, focused primarily on the development of post-surgical anti-infection pipeline, announced today ...
Biopharmaceuticals, Venture Capital, Personnel
PolyPid, BonyPid-1000, D-PLEX

Carillon Mitral Contour System Associated with Significant Improvement of Functional Mitral Regurgitation

周三, 02/24/2016 - 13:15
KIRKLAND, Wash.--(Healthcare Sales & Marketing Network)--A single-center study recently published in the Journal of Invasive Cardiology noted that treatment with Cardiac Dimensions’ Carillon® Mitral Contour System® resulted in significant improveme...
Devices, Interventional, Cardiology
Cardiac Dimensions, Mitral Contour, mitral regurgitation, annuloplasty

TransMedics Announces The World's First Human Liver Transplantation Using The Organ Care System (OCS(TM)) Liver Technology and The Initiation of The OCS(TM) Liver PROTECT U.S. Pivotal Trial

周二, 02/23/2016 - 15:49
ANDOVER, Mass., Feb. 23, 2016 -- (Healthcare Sales & Marketing Network) -- TransMedics, Inc., the global leader in portable ex-vivo warm perfusion of donor organs for transplantation, announces the world's first human liver transplantation using the OCS™ ...
Devices, Surgery
TransMedics, Organ Care System, liver transplant, transplantation

OrthoGrid(R) Systems, Inc. Announces The New HipGrid(R) Drone(TM) at AAHKS

周二, 02/23/2016 - 15:46
SALT LAKE CITY, Feb. 23, 2016 -- (Healthcare Sales & Marketing Network) -- OrthoGrid Systems, Inc. recently announced the release of the new HipGrid Drone at the American Association of Hip and Knee Surgeons (AAHKS) 25th Annual Meeting held in Dallas last...
Devices, Orthopaedic, Product Launch
OrthoGrid Systems, HipGrid DRONE, Total Hip Replacement

PTC Receives Refuse to File Letter from FDA for Translarna(TM) (ataluren)

周二, 02/23/2016 - 15:43
SOUTH PLAINFIELD, N.J., Feb. 23, 2016 -- (Healthcare Sales & Marketing Network) -- PTC Therapeutics, Inc. (PTCT) today announced that it received yesterday evening a Refuse to File letter from the United States Food and Drug Administration (FDA) regarding...
Biopharmaceuticals, FDA
PTC Therapeutics, Translarna, ataluren, Duchenne muscular dystrophy

Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia

周二, 02/23/2016 - 15:34
FDA-Approved ACUITY™ X4 Quadripolar Left Ventricular Leads to be used in Trial Pursuing MRI Labeling for Cardiac Defibrillation and Resynchronization Systems MARLBOROUGH, Mass., Feb. 23, 2016 -- (Healthcare Sales & Marketing Network) -- Boston Scientif...
Devices, Cardiology, FDA
Boston Scientific, Quadripolar Leads, cardiac resynchronization therapy

SIRFLOX Study Published in Journal of Clinical Oncology

周二, 02/23/2016 - 15:30
Prestigious ASCO Journal Publishes 530-patient SIRFLOX Study on SIR-Spheres® Y-90 resin microspheres in the Management of Metastatic Colorectal Cancer (mCRC) SYDNEY, February 23, 2016 -- (Healthcare Sales & Marketing Network) --Sirtex Medical Limit...
Devices, Interventional, Radiology, Oncology
Sirtex Medical, SIR-Spheres, SIRFLOX, liver metastases

CollPlant Receives CE Mark for Vergenix(TM) FG Wound Filler

周二, 02/23/2016 - 15:25
NESS ZIONA, Israel, February 23, 2016 -- (Healthcare Sales & Marketing Network) -- CollPlant Ltd. (CLPT.TA), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products, today announced that it ha...
Devices, Regenerative Medicine, Wound Care, Regulatory
CollPlant, Vergenix, Wound Filler

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong